Grange, P.A.; Ollagnier, G.; Beauvais Remigereau, L.; Nicco, C.; Mayslich, C.; Marcelin, A.-G.; Calvez, V.; Dupin, N.
A New Topical Candidate in Acne Treatment: Characterization of the Meclozine Hydrochloride as an Anti-Inflammatory Compound from In Vitro to a Preliminary Clinical Study. Biomedicines 2022, 10, 931.
https://doi.org/10.3390/biomedicines10050931
AMA Style
Grange PA, Ollagnier G, Beauvais Remigereau L, Nicco C, Mayslich C, Marcelin A-G, Calvez V, Dupin N.
A New Topical Candidate in Acne Treatment: Characterization of the Meclozine Hydrochloride as an Anti-Inflammatory Compound from In Vitro to a Preliminary Clinical Study. Biomedicines. 2022; 10(5):931.
https://doi.org/10.3390/biomedicines10050931
Chicago/Turabian Style
Grange, Philippe A., Guillaume Ollagnier, Laurianne Beauvais Remigereau, Carole Nicco, Constance Mayslich, Anne-Geneviève Marcelin, Vincent Calvez, and Nicolas Dupin.
2022. "A New Topical Candidate in Acne Treatment: Characterization of the Meclozine Hydrochloride as an Anti-Inflammatory Compound from In Vitro to a Preliminary Clinical Study" Biomedicines 10, no. 5: 931.
https://doi.org/10.3390/biomedicines10050931
APA Style
Grange, P. A., Ollagnier, G., Beauvais Remigereau, L., Nicco, C., Mayslich, C., Marcelin, A.-G., Calvez, V., & Dupin, N.
(2022). A New Topical Candidate in Acne Treatment: Characterization of the Meclozine Hydrochloride as an Anti-Inflammatory Compound from In Vitro to a Preliminary Clinical Study. Biomedicines, 10(5), 931.
https://doi.org/10.3390/biomedicines10050931
